PCCTC Medical Director Discusses Biomarkers in Prostate Cancer

December 18, 2018 | Press Releases

Dr. Michael Morris describes the need to be stratified by risk through biomarkers.

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.